The evolution of percutaneous nephrolithotomy: Analysis of a single institution experience over 25 years.


Journal

Canadian Urological Association journal = Journal de l'Association des urologues du Canada
ISSN: 1911-6470
Titre abrégé: Can Urol Assoc J
Pays: Canada
ID NLM: 101312644

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 1 8 2019
medline: 1 8 2019
entrez: 1 8 2019
Statut: ppublish

Résumé

Over time, the incidence of nephrolithiasis has risen significantly, and patient populations have become increasingly complex. Our study aimed to determine the impact of changes in patient demographics on percutaneous nephrolithotomy (PCNL) outcomes. A retrospective analysis of a prospectively collected database was carried out from 1990-2015. Patient demographics, comorbidities, stone and procedure characteristics were analyzed. Multivariate logistic regression was used to evaluate differences in operative duration, complications, stone-free rate, and length of stay. A total of 2486 patients with a mean age of 54±15 years, body mass index (BMI) of 31±8, and stone surface area of 895±602 mm Despite an increasingly complex patient population, PCNL remains a safe and effective procedure with a high stone-free rate and low risk of complications.

Identifiants

pubmed: 31364972
pii: cuaj.5725
doi: 10.5489/cuaj.5725
pmc: PMC6788910
doi:

Types de publication

Journal Article

Langues

eng

Pagination

E317-E324

Références

J Urol. 1992 May;147(5):1219-25
pubmed: 1569653
Scand J Urol Nephrol. 1976;10(3):257-9
pubmed: 1006190
J Endourol. 2014 Sep;28(9):1078-84
pubmed: 24832220
J Endourol. 2011 Jan;25(1):11-7
pubmed: 21247286
J Endourol. 2016 Aug;30(8):864-70
pubmed: 27257037
BJU Int. 2008 Mar;101(5):535-9
pubmed: 17922862
J Endourol. 2004 Oct;18(8):715-22
pubmed: 15659890
J Endourol. 2011 Feb;25(2):327-33
pubmed: 21214412
JAMA. 2001 Sep 12;286(10):1195-200
pubmed: 11559264
Urology. 2011 Aug;78(2):277-81
pubmed: 21333334
Eur Urol. 2005 Jan;47(1):22-8
pubmed: 15582245
Urology. 2012 Jan;79(1):55-60
pubmed: 21855965
Eur Urol. 2014 Oct;66(4):724-9
pubmed: 25015037
J Urol. 2015 Dec;194(6):1646-51
pubmed: 26144334
Int Braz J Urol. 2015 Jan-Feb;41(1):86-90
pubmed: 25928513
Urology. 2014 Jun;83(6):1248-53
pubmed: 24612615
J Endourol. 2017 Jun;31(6):547-556
pubmed: 28095709
Eur Urol. 2016 Aug;70(2):382-96
pubmed: 26876328
J Urol. 2014 Nov;192(5):1450-6
pubmed: 24866599
J Urol. 2012 Jul;188(1):138-44
pubmed: 22591971
BJU Int. 2013 Apr;111(4):628-32
pubmed: 22958458
J Endourol. 2011 Jun;25(6):933-9
pubmed: 21568697
J Endourol. 2012 Aug;26(8):996-1001
pubmed: 22494028
World J Urol. 2017 Sep;35(9):1301-1320
pubmed: 28213860
Urology. 2016 May;91:41-5
pubmed: 26919962
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Eur Urol. 2007 Apr;51(4):899-906; discussion 906
pubmed: 17095141
J Endourol. 2008 Jan;22(1):35-40
pubmed: 18095862
J Urol. 2009 Mar;181(3):1163-8
pubmed: 19152935
Eur Urol. 2012 Jan;61(1):146-58
pubmed: 21978422
J Endourol. 2017 Aug;31(8):742-750
pubmed: 28557565
Kidney Int. 2003 May;63(5):1817-23
pubmed: 12675858
Eur Urol. 2015 Jan;67(1):125-137
pubmed: 25064687
J Endourol. 2013 Aug;27(8):979-83
pubmed: 23590615
J Urol. 1995 Mar;153(3 Pt 1):604-8
pubmed: 7861493
Korean J Urol. 2013 Jul;54(7):448-53
pubmed: 23878687
J Urol. 2013 Aug;190(2):558-64
pubmed: 23434944
J Endourol. 2011 Aug;25(8):1275-80
pubmed: 21751882

Auteurs

Jennifer Bjazevic (J)

Division of Urology, Western University, London, ON, Canada.

Linda Nott (L)

Division of Urology, Western University, London, ON, Canada.

Philippe D Violette (PD)

Division of Urology, McMaster University, Hamilton, ON, Canada.

Thomas Tailly (T)

Division of Urology, Ghent University, Ghent, Belgium.

Marie Dion (M)

Niagara Health System, ON, Canada.

John D Denstedt (JD)

Division of Urology, Western University, London, ON, Canada.

Hassan Razvi (H)

Division of Urology, Western University, London, ON, Canada.

Classifications MeSH